Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

99mTc-fanolesomab Palatin Technologies.

Charito Love¹, Christopher J Palestro

¹Long Island Jewish Medical Center, Division of Nuclear Medicine, 270-05 76th Avenue, New Hyde Park, NY 11040, USA.

Idrugs : the Investigational Drugs Journal

|November 6, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Importance of Region-of-Interest Placement in Gastric Emptying Studies with Small Bowel Activity at Time 0.

Journal of nuclear medicine technology·2026

Same author

Corrigendum to 'Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms' [Experimental and Molecular Pathology 94 (2013) 466-473].

Experimental and molecular pathology·2026

Same author

Effect of truncating blood sampling in measuring glomerular filtration rate.

American journal of nuclear medicine and molecular imaging·2025

Same author

EANM/SNMMI guideline/procedure standard for [<sup>18</sup>F]FDG hybrid PET use in infection and inflammation in adults v2.0.

European journal of nuclear medicine and molecular imaging·2024

Same author

Summary: Appropriate Use Criteria for the Use of Nuclear Medicine in Fever of Unknown Origin.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2024

Same author

Effect of PSMA PET/CT on the Use of Bone Scintigraphy for Prostate Cancer at a University Hospital System.

Journal of nuclear medicine technology·2024

Technetium-99m-fanolesomab (99mTc-fanolesomab) is an investigational radiolabeled agent for diagnosing infections like appendicitis and osteomyelitis. This novel imaging tool shows promise in identifying infectious diseases.

Area of Science:

Nuclear medicine
Radiopharmaceutical development
Infectious disease diagnostics

Background:

Accurate diagnosis of infections such as appendicitis and osteomyelitis is crucial for timely treatment.
Current diagnostic methods may have limitations in specificity or invasiveness.

Purpose of the Study:

To introduce 99mTc-fanolesomab as a novel radiolabeled imaging agent.
To highlight its potential application in diagnosing specific infections.

Main Methods:

Development of 99mTc-fanolesomab by Palatin Technologies.
Utilizing radiolabeling techniques for diagnostic imaging.

Main Results:

99mTc-fanolesomab is under development as an imaging agent.

Related Experiment Videos

It is being investigated for diagnostic use in infections.

Conclusions:

99mTc-fanolesomab represents a potential advancement in the diagnostic imaging of infections.
Further development is ongoing for its clinical application in conditions like appendicitis and osteomyelitis.